Mark Emmanuel Cooper
Mark Emmanuel Cooper publishes mostly in Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Chronic Kidney Disease and Diabetes, Advanced Glycation End Products research and Diabetes Treatment and Management.
- World rank
- #42,323 of 7,710,434 ranked researchers
- Rank in Australia
- #1,265 of 140,210
- Works
- 704
- Citations
- 67k
- Citations per work
- 94.8
What does Mark Emmanuel Cooper research?
Mark Emmanuel Cooper's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences36051.2%
- Medicine36051.2%
- Everything else23233.0%
- Life Sciences11115.8%
- 1Nephrology18% of their works
- 2Endocrinology, Diabetes and Metabolism17% of their works
- 3Cardiology and Cardiovascular Medicine12% of their works
- 4Molecular Biology8% of their works
- 5Clinical Biochemistry8% of their works
- 6Surgery4% of their works
Research topics
Which keywords describe Mark Emmanuel Cooper's research?
The keywords of their largest research topics: Cardiovascular Disease, Global Burden, Fibrosis, Diabetes, Chronic Kidney Disease, Glomerular Filtration Rate, Clinical Guidelines and Inflammation.
- Continuous Glucose Monitoring
- Aldosterone
- Insulin Resistance
- Angiotensin
- Blood Pressure
- Cardiovascular Events
- Cardiovascular Outcomes
- Advanced Glycation End Products
- Glycemic Control
- Inflammation
- Glomerular Filtration Rate
- Diabetes
- Global Burden
- Cardiovascular Disease
- Fibrosis
- Chronic Kidney Disease
- Clinical Guidelines
- Hypertension
- Insulin Therapy
- HMGB1
- Type 2 Diabetes
- Antihypertensive Drugs
- Metabolic Syndrome
- Renin
- Obesity
- Primary Aldosteronism
- Hypoglycemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 27 words, with their numbers
- Cardiovascular Disease5025 topics
- Global Burden3402 topics
- Fibrosis3282 topics
- Diabetes3034 topics
- Chronic Kidney Disease2471 topic
- Glomerular Filtration Rate2471 topic
- Clinical Guidelines2332 topics
- Inflammation2222 topics
- Hypertension2133 topics
- Glycemic Control1772 topics
- Insulin Therapy1772 topics
- Advanced Glycation End Products1411 topic
- HMGB11411 topic
- Cardiovascular Outcomes1401 topic
- Type 2 Diabetes1401 topic
- Cardiovascular Events1322 topics
- Antihypertensive Drugs931 topic
- Blood Pressure931 topic
- Metabolic Syndrome832 topics
- Angiotensin811 topic
- Renin811 topic
- Insulin Resistance441 topic
- Obesity441 topic
- Aldosterone391 topic
- Primary Aldosteronism391 topic
- Continuous Glucose Monitoring371 topic
- Hypoglycemia371 topic
Where does Mark Emmanuel Cooper work?
Mark Emmanuel Cooper's main affiliation in the publication record is Baker Heart and Diabetes Institute, Australia.
How many publications and citations does Mark Emmanuel Cooper have?
OpenAlex counts 704 works and 66,774 citations for Mark Emmanuel Cooper, an h-index of 124, ranking #42,323 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Emmanuel Cooper. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.